Optafenac
Cheaper & Alternative Brands
Same generic (Nepafenac), same form (Ophthalmic Suspension)
Clinical Prescribing Information
Medical monograph and safety information for healthcare professionals & patients.Indications & Clinical Uses
N-Fenac TS 0.1% Ophthalmic Suspension:
The treatment of post-operative ocular pain and inflammation including cataract surgery
Inhibition of surgery induced miosis and
Prevention of post-operative cystoid macular edema (CME).
N-Fenac TS 0.3% Ophthalmic Suspension:
Post-operative pain and inflammation associated with cataract surgery.
Dosage & Administration
Nepafenac 0.1% Sterile Ophthalmic Suspension-
For post-operative pain & inflammation:
Instill 1 drop 3 times daily 1 day prior to cataract surgery and continued on the day of surgery and through the first 2 weeks of the post-operative period.
For surgery induced miosis
: Instill 1 drop 3 times daily 1 day before surgery & on the day of surgery.
For prevention of post-operative CME:
Instill 1 drop 3 times daily 1 day before surgery and continued on the day of surgery and through the first 6 weeks of the post-operative period.
Nepafenac 0.3% Sterile Ophthalmic Suspension-
For post-operative pain & inflammation:
Instill 1 drop once daily 1 day prior to cataract surgery and continued on the day of surgery and through the first 2 weeks of the post-operative period. An additional drop should be administered 30 to 120 minutes prior to surgery.
Use in children
: Safety and effectiveness in pediatric patients below 18 years of age have not been established.
Use in elderly patients
: No overall differences in safety or effectiveness have been observed between elderly and younger patients.
Contraindications
Contraindicated in patients with previously demonstrated hypersensitivity to any of the ingredients in the formulation or to other NSAIDs.
Side Effects & Adverse Reactions
Reported side effects are foreign body sensation, lid margin crusting, ocular discomfort, ocular hyperemia etc.
Warnings & Precautions
N-Fenac TS should be used with caution in patients with known bleeding tendencies or who are receiving medications which may prolong bleeding time.
Pharmacology & Mechanism of Action
Nepafenac is a nonsteroidal anti-inflammatory prodrug (NSAID). After instillation in the eye, it penetrates the cornea and is converted by ocular tissue hydrolase to Amfenac, a potent nonsteroidal anti-inflammatory drug. Amfenac is thought to inhibit the action of cyclooxygenase enzyme. This enzyme is required for prostaglandin synthesis.